Original studies indicated that DUSP22 rearrangement was linked to an encouraging five-year OS rate akin to that of ALK-positive ALCL, yet subsequent research has failed to uphold this finding [221]. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.